Introduction {#Sec1}
============

Plant cell expansion depends on the interplay between internal driving forces and the controlled yielding of the cell wall. The ability of the wall to extend under this internal pressure is largely determined by wall loosening processes that modify the interaction of cellulose microfibrils with one another, and/or with hemicelluloses (Darley et al. [@CR10]). Likewise, organ growth is brought about by differential rates of wall loosening, which causes differential tissue growth and, consequently, tissue tension within the organ (Peters and Tomos [@CR26], [@CR27]). Thus, progressive modification of the cellulose--hemicellulose (mostly cellulose--xyloglucan) networks is important in plant development.

In addition to their effect on plant growth, there are indications that interactions of hemicelluloses with cellulose can affect cellulose fibre properties. Using the Acetobacter model system, it was shown that cellulose--glucomannan and cellulose--galactomannan composites cause 57 and 32% loss of the crystallinity, respectively, of the native bacterial cellulose (Whitney et al. [@CR43]). For cellulose--xyloglucan composites 29% loss of cellulose crystallinity was observed (Whitney et al. [@CR45]). It was also shown that the composites were less stiff, leading to a dramatic reduction in mechanical strength, for example 80% reduction in composites with xyloglucan (Whitney et al. [@CR45], [@CR44]). There are also reports which indicate that fibre properties depend on the side-chain substitution of the hemicelluloses. Studies on *Arabidopsis thaliana* mutants with mutations of the *MUR2* and *MUR3* genes, which encode xyloglucan-specific fucosyl and galactosyl transferases, respectively, revealed that the tensile strength of the fibre was enhanced by galactosylation of the xyloglucan (Pena et al. [@CR25]; Ryden et al. [@CR29]).

There are indications that the interactions between mannan-based polysaccharides and cellulose can affect the structural properties of the cell wall (Carpita et al. [@CR5]; Hosoo et al. [@CR16]). An immuno-localisation study of *A. thaliana* revealed that mannans were present in all thickened cell walls of stems and leaves, including those of the xylem parenchyma and epidermis (Handford et al. [@CR13]). Mannan transglycosylase was recently identified and characterized as cell wall enzyme acting on mannan-based plant polysaccharides in primary cell walls of higher plants (Schroder et al. [@CR31]). This body of evidence thus supports an emerging idea that mannan-based polysaccharides in cell walls may have a role analogous to that of xyloglucans, introducing flexibility and forming a growth-restraining network with cellulose.

Proteins, for example expansins, have been shown to be involved in modifying cellulose--hemicellulose interaction, thereby loosening the cell wall and ultimately regulating growth and developmental processes in which rearrangements in the cell wall are thought to be important (Cho and Cosgrove [@CR7]; Choi et al. [@CR8]; Pien et al. [@CR28]; Zenoni et al. [@CR47]). There is evidence that (heterologous) carbohydrate-binding modules (CBMs) could also affect these interactions (Levy et al. [@CR22]; Shpigel et al. [@CR33]), leading to altered structural morphology in transgenic plants (Kilburn et al. [@CR17]; Quentin [@CR4]; Shoseyov et al. [@CR32]) or plant growth (Safra-Dassa et al. [@CR30]). CBMs are non-catalytic polysaccharide-recognizing modules, appended to glycoside hydrolases, that often degrade water-insoluble polysaccharides and concentrate the enzymes on their target polysaccharides. CBMs are grouped into families based on amino acid sequence similarities; there are currently 47 families of CBMs in the database (<http://www.afmb.cnrs-mrs.fr/CAZY/>). The biochemical characteristics of members of most of the CBM families have been established, including those that target non-cell wall polysaccharides such as starch and glycogen (reviewed by Boraston et al. [@CR3]). Although most CBMs are linked to the catalytic modules of carbohydrate-active enzymes, some non-catalytic carbohydrate-binding proteins are not appended to any catalytic module. Examples of such proteins include putative CBMs of the *A. thaliana* former X8 family, now CBM43 (GenBank accession no. AL161503) (Henrissat et al., [@CR15]), with olive pollen allergen Ole e 10 (GenBank accession no. AY082335) being the first characterized member of this family (Barral et al. [@CR1]). Another example is the non-catalytic protein (NCP1) (CBM29; GenBank accession no. AY026754), which is a component of the anaerobic fungus *Piromyces equi* cellulase--hemicellulose complex (Freelove et al. [@CR12]).

Because of the heterogeneous nature of the cell wall polysaccharides, several CBMs have evolved structures which enable them to recognize more than one wall polysaccharide (Boraston et al. [@CR3]). Promiscuous recognition of carbohydrates by CBMs enables the associated enzyme (complex) to be more efficient in cell wall degradation. McCartney et al. ([@CR24]) showed that different xylan-specific CBM families can vary substantially in their binding to the cell wall. This indicates that the specificity of CBMs is so intricate that after expression *in planta* their effects on cell wall modification might be very local. To really affect wall architecture, it might be important to select CBMs that bind to different kinds of polysaccharide (promiscuous), so that the effect is not confined to one location or cell type. Most research activity relating to the potential use of CBMs for plant cell wall modification has been on cellulose-specific CBMs. In this investigation we have used different CBMs which not only recognise hemicellulose as opposed to CBM3 but are also to some extent promiscuous.

The CBM29 modules are an excellent model of promiscuity in protein--carbohydrate recognition. The modules bind soluble glucomannan, galactomannan, β-glucan, and hydroxyethylcellulose (HEC), and insoluble forms of cellulose and mannan (Charnock et al. [@CR6]; Freelove et al. [@CR12]). For all the ligands tested two appended copies of CBM29 (CBM29-1-2) had affinity substantially higher than the additive value of the individual modules. This indicates the two CBMs act in synergy to bind all their target ligands, with CBM29-2 having more affinity than CBM29-1. The tandem CBM29-1-2 was, additionally, able to interact with xyloglucan and different forms of xylans, whereas the single CBM had little affinity for these polysaccharides (Freelove et al. [@CR12]; McCartney et al. [@CR23]). An ex-situ labelling study has revealed that the tandem CBM29-1-2 modules bind strongly to the cell walls of the maize coleoptile sheath and the enclosed developing leaves (McCartney et al. [@CR23]). This is indicative of the great abundance of their interacting ligands in the primary cell walls of grasses. It was therefore of interest to investigate the heterologous expression of these promiscuous CBMs in plants, and, more importantly, to compare their effects with those of less promiscuous CBMs, whose characteristics are described below.

Some ligand promiscuity is also observed for two consecutive family 2b CBMs (CBM2[b]{.ul}-1 and CBM2[b]{.ul}-2) from *Cellulomonas fimi* xylanase 11A. The tandem CBM2[b]{.ul}-1-2 (note the underlining used throughout this report to distinguish it from CBM29-1-2) has very strong affinity for xylan and much lower affinity for insoluble acid-swollen cellulose (Bolam et al. [@CR2]). It also has an 18 to 20-fold greater affinity for xylan than the individual modules.

We have expressed two CBM29 constructs, the tandem CBM29-1-2 and the single derivative CBM29-2, and the tandem CBM2[b]{.ul}-1-2 construct in tobacco (all proteins targeted the cell wall) under the control of 35S cauliflower mosaic virus (CaMV) promoter. It is shown that cell wall structural alterations in transgenic plants expressing CBM29-1-2 are more severe than those in CBM2[b]{.ul}-1-2 transformants. Our results indicate that promiscuous carbohydrate binding modules can modulate cell wall structure and the development of transgenic tobacco plants.

Materials and methods {#Sec2}
=====================

Preparation of constructs {#Sec3}
-------------------------

Three constructs were prepared for expression in tobacco plants, one for single CBM29-2, one for tandem CBM29-1-2, and one for tandem CBM2[b]{.ul}-1-2. The CBM29 and CBM2[b]{.ul}-1-2 constructs were prepared by amplifying their respective gene fragments from pET22b and pET28a, recombinant plasmid vectors used for cloning and expression in *Escherichia coli* (Bolam et al. [@CR2]; Freelove et al. [@CR12]). For the CBM29-1-2 fragment the polymerase chain reaction (PCR) was performed using primers that included *Bam*HI and SmaI recognition sites (5′- cg[ggatcc]{.ul}gttagtgctacttactctgttgtttat-3′ and 5′-tcc[cccggg]{.ul}cctt**tta**atttattgggtcaacgaaa-3′; the *Bam*HI and SmaI sites, respectively, are underlined). The three bases highlighted in bold type are the stop codon. The amplified 914-base-pair fragment of the tandem CBM29-1-2 was digested with BamHI and SmaI (Invitrogen, The Netherlands) and cloned into a similarly digested binary vector pGreen7k (Hellens et al. [@CR14]). Similarly, amplification of the single CBM29-2 fragment were performed using primers with the same restriction sites as for the tandem CBM29-1-2 (5′-cg[ggatcc]{.ul}cgtaatgtcagagccacttacactgt-3′ and 5′-tcc[cccggg]{.ul}cctt**tta**atttattgggtcaacgaaa-3′; the *Bam*HI and SmaI sites, respectively, are underlined). The amplified 559-base-pair fragment was digested with *Bam*HI and SmaI (Invitrogen, The Netherlands) and cloned into pGreen7k binary vector. Similarly, amplification and cloning of the 635-base-pair CBM2[b]{.ul}-1-2 fragment were performed using primers that included *Sma*I and *Eco*RI recognition sites at either end (5′-[cccggg]{.ul}tgacacgggcggaggcggcggt-3′ and 5′-g[gaattc]{.ul}**tca**gcccgtggcgca-3′; the *Sma*I and *Eco*RI sites, respectively, are underlined). The cloning of the three fragments was in-frame with fusion peptides of two sequences, which were cloned upstream in the binary vector. The first sequence codes for a tobacco transit peptide for transporting a cellular glycoprotein NTP303 across the plasma membrane into the cell wall (Wittink et al. [@CR46]) whereas the second sequence encodes a hexahistidine tag. The sequence of the transit peptide was obtained as a product of annealing two oligonucleotide primers, TP1 (5′- [agctt]{.ul}atgggaagtggtaaagtaacatttgtggctttgctactttgcctctccgtaggggtgatagctt-3′) and TP2 (5′-[ctaga]{.ul}agctatcacccctacggagaggcaaagtagcaaagccacaaatgttactttaccacttcccata-3′). The underlined nucleotides produced overhangs of *Hin*dIII and *Xba*I, respectively. This fragment was then cloned into the *Hin*dIII and *Xba*I cloning sites of the vector. Similarly, the sequence of the hexahistidine tag was obtained and ligated into *Xba*I and *Bam*HI sites as annealing product of His1 (5′-[ctagaa]{.ul}gaggatcgcatcaccatcaccatcacg-3′) and His2 (5′-[gatcc]{.ul}gtgatggtgatggtgatgcgatcctctt-3′), with the underlined nucleotides producing overhangs of *Xba*I and *Bam*HI, respectively. The purpose of using the hexahistidine tag was to facilitate affinity purification of the CBM29 proteins. The control construct did not contain any of the CBMs, the transit peptide, or the hexahistidine epitope tag. All constructs were sequenced to verify their integrity.

Immunofluorescence detection of CBM29-1-2 and CBM2[b]{.ul}-1-2 binding and microscopy {#Sec4}
-------------------------------------------------------------------------------------

Wild-type tobacco plants (*Nicotiana tabacum* L.) were grown at 24°C under 16 h light and 8 h dark for 6--7 weeks. Regions of stem were excised and immediately fixed in PEM buffer (50 mmol L^−1^ PIPES (piperazine-*N*,*N*′-bis\[2-ethanesulfonic acid\]), 5 mmol L^−1^ EGTA (ethylene glycol bis(β-aminoethyl ether)-*N*,*N*,*N*′*N*′-tetraacetic acid), and 5 mmol L^−1^ MgSO~4~, pH 6.9) containing 4% paraformaldehyde. Samples were then dehydrated in an ethanol series (30, 50, 70, 90, and 97%, each for 30 min at 4°C, ethanol and wax 1:1, 37°C, overnight) and embedded in Steedman's wax. Sections were cut to a thickness of 12 μm and collected on polylysine-coated microscope slides (BDH Laboratory Supplies, Dorset, UK), de-waxed, and re-hydrated through a reverse ethanol series into phosphate-buffered saline (PBS) (97% for 3 × 10 min, 90%, 50% and water for 10 min each, and a final step of water 90 min). For CBM labelling, sections were incubated in milk protein/PBS (to reduce any non-specific binding of proteins) and 5 μg mL^−1^ CBM29-1-2 for 1.5 h. Immunofluorescence detection of binding of CBM29-1-2 and CBM2[b]{.ul}-1-2 to sections and microscopy were performed as described elsewhere (McCartney et al. [@CR23]).

Tobacco transformation and regeneration {#Sec5}
---------------------------------------

In vitro leaf explants of *N. tabacum* cv. Samsun NN were used for *Agrobacteriumtumefaciens*-mediated transformation. Cloned binary vector pGreen7k was co-transformed with the helper plasmid pSoup (Hellens et al. [@CR14]) into *A.tumefaciens* strain LBA4404 by electroporation. This was plated out on LB-agar plates containing kanamycin (100 μg mL^−1^) and rifampicin (30 μg mL^−1^), and incubated for three days at 28°C, to obtain single colonies. The integrity of the binary plasmids was tested by restriction analysis of plasmids isolated from *A. tumefaciens* cultures used for plant transformation. LB medium (20 mL) without selection was inoculated with a single colony and incubated overnight at 28°C. The grown culture (100 μL) was added to a Petri dish containing 10 mL Murashige--Skoog (MS30). Leaf explants, without major veins and edges, from young seedlings were transferred upside-down in to the MS30 medium. *Agrobacterium* infection was performed in the dark for 2 days at 24--25°C. Two controls were used for the procedure, untransformed wild-type control and empty pGreen7k control without an insert. Leaf explants were washed in three changes of liquid washing medium of MS30 with 250 mg L^−1^ carbenicillin. The washed explants were transferred upside-up to an MS30-phytagel plate containing 0.1 mg L^−1^ α-naphthalene acetic acid (NAA), 1 mg L^−1^ 6-benzylaminopurine (BAP), 200 mg L^−1^ kanamycin and 250 mg L^−1^ carbenicillin, and incubated overnight in the dark at 28°C. Plants were transferred to a growth chamber (25°C), where they were gradually adapted to light and incubated for callus induction. After two weeks in culture, calli generated were transferred to shoot-inducing medium, MS20-phytagel, containing 0.2 mg L^−1^ NAA, 2 mg L^−1^ BAP, 200 mg L^−1^ kanamycin, and 250 mg L^−1^ carbenicillin. Well-formed shoots were harvested and transferred to root-inducing medium, MS15-phytagel plate containing 100 mg L^−1^ kanamycin, 250 mg L^−1^ carbenicillin, and 200 mg L^−1^ vancomycin. Transformed plantlets were transferred to the greenhouse to generate mature plants. Between fifteen to eighteen antibiotic-resistant tobacco transformants were generated for each of the three CBM transgenes.

RNA gel blot analysis of transgenic plants {#Sec6}
------------------------------------------

Total RNA was isolated from 3 to 5 g transformed in-vitro shoots as described elsewhere (Kuipers et al. [@CR18]). Aliquots of 20 μg per lane were separated on a 1% formaldehyde agarose gel and blotted onto a Hybond-N nylon membrane (Amersham) by vacuum transfer in 0.4 mol L^−1^ sodium hydroxide. The membranes were hybridized with probes consisting of 60 ng \[α32P\]dCTP-labelled restricted fragments of CBM29-1-2, CBM29-2, or CBM2[b]{.ul}-1-2. The radioactive labelled blots were exposed to X-OMAT S and AR scientific imaging films (Kodak) at −80°C. The blots were re-hybridized, after stripping, with a 489 bp \[α32P\]dCTP-labelled fragment of a tobacco 18S ribosomal RNA gene (GenBank accession no. AJ236016), as a control. The ribosomal probe was amplified from tobacco genomic DNA using oligonucleotides 5′-gaaactgcgaatggctcatt-3′and 5′-attaccgcggctgctggc-3′ for PCR amplification.

Protein extraction {#Sec7}
------------------

Protein extracts were prepared from transformed tobacco stems using 250 mmol L^−1^ sodium phosphate buffer (pH 6.0), 0.5 mol L^−1^ NaCl, 5 mmol L^−1^ EDTA, 0.1% (*v*/*v*) Tween 20, protease inhibitor (Complete, Roche), 37.5 mg mL^−1^ PVPP (adapted from Vincken et al. [@CR41]). The protein samples were incubated for 2 h at 4°C with gentle shaking. After incubation the samples were centrifuged at 4,500*g* and 4°C for 20 min. The supernatant containing the soluble protein fraction was then collected. The protein samples were then concentrated with Centricon Plus-20 devices (Millipore) according to supplier's procedure. Protein concentrations were determined with an ESL protein assay (Roche) using BSA as standard.

Incubation of RGS·(HIS)~6~-tagged size marker in protein extract of wild-type tobacco {#Sec8}
-------------------------------------------------------------------------------------

Protein extracts were prepared from wild-type tobacco as described above, either lacking or supplemented with 5 mmol L^−1^ EDTA and protease inhibitor (Complete, Roche). RGS·(HIS)~6~-tagged size marker was incubated with the protein extracts as follows. A batch of RGS·(HIS)~6~-tagged size marker (Qiagen) was dissolved in 100 μL 50 mmol L^−1^ Tris, pH 7.5, such that the final concentration of the individual proteins varied from 50 to 75 ng μL^−1^. The epitope-tagged size marker (2 μL) was added to 18 μL tobacco extracts. The mixtures were incubated at room temperature for approximately 15 h. As a control, RGS·(HIS)~6~-tagged size marker was incubated in 50 mmol L^−1^ Tris, pH 7.5.

Western blot analysis {#Sec9}
---------------------

The protein samples were separated with SDS-PAGE on 12% SDS-polyacrylamide gels (Mini-Protean II apparatus, Bio-Rad). The separated proteins were electroblotted on to a nitrocellulose membrane in 192 mmol L^−1^ glycine, 25 mmol L^−1^ Tris base, 0.1% (*w*/*v*) SDS, 20% (*v*/*v*) ethanol, pH 8.3. Blocking against non-specific binding was performed for 2 h with 3% (*w*/*v*) BSA (Sigma) in TBS (10 mmol L^−1^ Tris, 150 mmol L^−1^ NaCl, pH 7.5). The membrane was then incubated with a 1:1000 dilution of the primary anti-RGS·HIS antibody (Qiagen) in TBS solution containing 3% (*w*/*v*) BSA for 2 h. The membrane was washed twice in TBS-TT buffer (20 mmol L^−1^ Tris base, 500 mmol L^−1^ NaCl, pH 7.5, 0.05% (*v*/*v*) Tween 20, 0.2% (*v*/*v*) Triton X-100), and once in TBS buffer, for 10 min each. The membrane was then washed with 1:2000 dilution horseradish peroxidase (HRP) conjugated sheep anti-mouse antibody (Amersham) in TBS buffer containing 10% (*w*/*v*) non-fat dried milk. The membrane was washed in TBS-TT buffer four times, 10 min each, and subsequently submerged in Supersignal ULTRA substrate working solution (Pierce), which is a mixture of equal parts of Ultra luminol/enhancer solution and Ultra stable peroxide solution. Finally, the membrane was exposed to X-OMAT S Scientific Imaging films (Kodak) at room temperature.

Monitoring the growth of the transformed plants {#Sec10}
-----------------------------------------------

To monitor growth of the transformed plants with time, three replicates per line were grown in the greenhouse. The transformants were grown in two series, the CBM29s and CBM2[b]{.ul}-1-2 series, with each series having its separate controls. Height measurements of the stems were taken weekly for nine weeks, starting from week two after transplant. The height measurements of six individual high expressers, each from transgenic lines containing CBM29-1-2 and CBM29-2 constructs, six transformed controls, and six untransformed controls from week 3 to week 9 were subjected to one-way analysis of variance (ANOVA), using an *α* of 0.05. To test whether the differential stem elongation was significant, a Fisher's unprotected least significant difference test was used. The null hypothesis of no difference between plant heights was rejected at an error of 0.05.

Light microscopy {#Sec11}
----------------

Three individual plants per transgenic tobacco line and three wild-type plants, as control, were used for microscopic examination. Three transgenic lines were used per construct (two high expressers and one low expresser). Stem samples were taken from the second internode from the top of the plant. Stem sections 1 mm-thick were fixed in 3% glutardialdehyde (Merck) and 3% paraformaldehyde (Merck) in 0.1 mol L^−1^ phosphate buffer containing 0.1% Triton X-100 for 2 h. The samples were then washed and dehydrated in an ethanol series. After dehydration they were embedded in Technovit 7100 resin (USA) (Kuroiwa et al. [@CR19]). Sections 4 μm-thick were stained with 0.1% toluidine blue (Aldrich) and examined under a bright field microscope.

Cryo-scanning electron microscopy and quantification of cell size and cell wall diameter {#Sec12}
----------------------------------------------------------------------------------------

One high expresser from each of the CBM29s and CBM2[b]{.ul}-1-2 transgenic lines and one individual plant each from their respective controls were used for cryo-SEM examination. The plants that were analysed were chosen on the basis of the results obtained from the extensive light microscopic analysis that showed a consistent pattern of alterations in high-expressing transgenic plants. Stem sampling was the same as for the light microscopy. Stem samples 6 mm-thick were mounted in a brass cylindrical sample holder with TBS tissue freezing medium (EMS, Washington, PA, USA). The frozen samples were placed in a sample holder in a cryo-ultra microtome (Reichert Ultracut E/FC4D) and cut at a specimen temperature of 100°C. These samples were first planed with a glass knife, after which the surface was planed with a diamond knife (Histo no trough, 8 mm 45°C; Drukker International, The Netherlands). After planing, the samples were placed in a dedicated cryo-preparation chamber (CT 1500 HF, Oxford instruments, UK). All the samples in the cryo-preparation chamber were freeze dried for 3 min at −90°C and 8 × 10^−4^ Pa, and subsequently sputtered with a 10-nm layer of Pt. The samples were cryo-transferred into the field emission scanning microscope (Jeol 6300F, Japan) on the sample stage at −190°C. All images were recorded digitally (Orion, 6 E.L.I. sprl, Belgium) at a scan rate of 100 s (full frame) at the size of 2,528 × 2,030, 8 bit. The images were optimized and resized for publication by use of Adobe Photoshop CS.

To quantify the micrographic images, files were opened with Image J software developed at the National Institute of Health, USA (<http://www.rsb.info.nih.gov/ij/>). The surface area of three hundred cortical and xylem cells was measured as shown by the insets in Figs. [7](#Fig7){ref-type="fig"}a and [7](#Fig7){ref-type="fig"}b. One hundred cells per field of view were measured in three replicates. Similarly, cell wall thickness of 150 cells was quantified as shown by the inset in Fig. [7](#Fig7){ref-type="fig"}c. Fifty cells per field of view were measured in three replicates. Standard deviations of three measurements were determined.

Isolation of cell wall material and analysis of the cellulose content {#Sec13}
---------------------------------------------------------------------

Stem samples from one high expresser of the CBM29 and CBM2[b]{.ul}-1-2 series, one pGreen7k vector control, and one wild-type control plant were ground to a fine powder in liquid nitrogen. For each isolation, 1 g of this stem material was extracted in a 50 mmol L^−1^ Tris\[HCl\], pH 7.2 solution containing 1% SDS, for 3 h at room temperature (RT) with continuous shaking. The cell wall material CWM was spun down by centrifugation at 13,000 rpm for 15 min. Subsequently, the residue was washed with water, ethanol, and acetone, then air-dried. The different cell wall materials (10 mg) were hydrolysed in 1 mL 2 mol L^−1^ TFA. The TFA-insoluble cellulose was spun down at 13,000 rpm for 15 min, and the pellet was suspended in 67% sulfuric acid. The suspension was heated and diluted appropriately to determine the cellulose content colorimetrically, using anthrone as colouring agent (Updegraff [@CR39]). The acid hydrolysis was performed in quadruplicate.

Results {#Sec14}
=======

Expression of bacterial CBM29 and CBM2[b]{.ul}-1-2 genes in tobacco {#Sec15}
-------------------------------------------------------------------

To detect expression of the introduced CBM genes in the tobacco plant, we performed Northern blot analysis with total RNA. Figure [1](#Fig1){ref-type="fig"} shows representatives of three classes of transcript expression (high, low, and none) of the three CBM modules as revealed by the Northern analysis. Ten of the CBM29-1-2 plants were classified as high expressers, five as low expressers, and two as none expressers. For the CBM29-2 plants, ten lines were classified as high expressers, seven as low expressers, and two as none expressers (note that none expressers may include plants with very low RNA expression, which could not be detected). For the CBM2[b]{.ul}-1-2 plants, six each were classified as high and low expressers whereas four plants were classified as none expressers. Preliminary attempts at purifying CBM proteins using affinity purification with the hexahistidine tag were not successful (data not shown). Similarly, Western detection of a hexahistidine epitope-tagged fungal elicitor protein ECP2 that was infiltrated into the apoplast of leaves did not succeed in the tomato plants but succeeded in *Arabidopsis thaliana* (van Esse et al. [@CR40]). The results indicated that the histidine tag was cleaved in the tomato plants but not in *A. thaliana*. These observations have since led to the idea that the hexahistidine epitope tags have cleavage sites recognized by proteases, which are specific for the cell walls of the *solanaceous* species. Fig. 1Transcript analysis of CBM29 and CBM2[b]{.ul}-1-2 genes in transgenic tobacco leaves. A differential transcript expression pattern is shown in the *upper panel* with the representative of each class in the three transgenic lines CBM29-2 (**a**), CBM29-1-2 (**b**) and CBM2[b]{.ul}-1-2 (**c**).*Line 14* in **a***line 5* in both **b** and **c**, represent high expressers. *Lines 9, 11 and 1* represent low expressers. *Line 17* in **a**, *line 6* in **b** and *line 14* in **c** represent none expressers. The *lower panel* shows RNA blots for the 18S ribosomal RNA internal control for each of the series

We corroborated this notion by incubating a protein ladder, consisting of five different proteins of known sizes, each containing an N-terminal RGS·(HIS)~6~--tag, in protein extracts of wild-type tobacco (Compier [@CR9]). The tagged proteins of the size marker that were incubated in tobacco extract without EDTA and protease inhibitor were not detectable on a Western blot whereas the markers incubated in extract supplemented with EDTA and protease inhibitor were detected. This suggested that extracts from tobacco contained proteases that could remove the hexahistidine epitope tag.

Because grinding of the plant material and protein extraction were performed at 4°C, and the protein extraction buffer contained EDTA and protease inhibitor, removal of the RGS·(HIS)~6~-tag from the fusion proteins had probably occurred already in planta, most probably extracellularly. It should be noted that with the presence of the NTP303 signal peptide, the fusion proteins would be secreted into the apoplast. Cleavage of the RGS·(HIS)~6~-tag was, therefore, likely to occur after translocation into the extracellular space.

CBM29-1-2 and CBM2[b]{.ul}-1-2 have different binding patterns in the stem {#Sec16}
--------------------------------------------------------------------------

Immunofluorescence detection of CBM29-1-2 and CBM2[b]{.ul}-1-2 binding to stems of the wild-type tobacco plant was performed order to determine, a priori, the particular tissues of the stem where the introduced CBM29-1-2 module would bind. Indirect immunofluorescence micrographs (Fig. [2](#Fig2){ref-type="fig"}) revealed that CBM2[b]{.ul}-1-2 binding is restricted to the secondary cell walls of stem vascular tissue---xylem cells and phloem fibres (Fig. [2](#Fig2){ref-type="fig"}a)---whereas CBM29-1-2 indiscriminately binds to every tissue of the stem, from the epidermis through the cortex and the vascular tissue to the pith parenchyma in the innermost part (Fig. [2](#Fig2){ref-type="fig"}b). In the control (no CBM) weak autofluorescence was observed in the xylem vessel cell walls (Fig. [2](#Fig2){ref-type="fig"}c). This ex-situ evidence for unselective binding of the CBM29-1-2 to both the primary and the secondary cell walls of the mature stem of the tobacco plant thus complements earlier evidence for its binding to a predominantly primary-walled maize coleoptile (McCartney et al. [@CR23]). It should also be noted that tobacco is a dicotyledonous plant whereas maize is monocotyledonous, and that there are many differences between the polysaccharide composition of the walls of these species. Both results thus confirm the binding promiscuity of the tandem CBM29-1-2, as previously characterized (Charnock et al. [@CR6]; Freelove et al. [@CR12]). We also conclude that the CBM2[b]{.ul}-1-2 ligands are present in the vascular tissue of the stem. Fig. 2Micrographs, obtained by indirect immunofluorescence microscopy, showing binding of CBM2[b]{.ul}-1-2 (**a**), CBM29-1-2 (**b**), and control (no CBM) (**c**) to transverse sections of wild-type tobacco stem. The CBM29-1-2 binds indiscriminately to every tissue of the stem, from the epidermis through the cortex and the vascular tissue to the pith parenchyma in the innermost part whereas CBM2[b]{.ul}-1-2 binding is restricted to the vascular tissues. *ct* cortical parenchyma, *xy* xylem cells, *ph* pith. *Arrow head* indicates the epidermis. *Arrow* indicates the phloem fibres. *Scale bar* = 100 μm

Reduced stem elongation and prolonged juvenility are observed for CBM29-1-2 transformants {#Sec17}
-----------------------------------------------------------------------------------------

An indication of reduced stem elongation in the transgenic plants expressing the tandem CBM29-1-2 was first apparent after the third week of transfer to the greenhouse. The different stem elongation of the tandem CBM29-1-2-expressing plants and the control plants became significant (*P* \< 0.05) at weeks seven and eight, when other plants had reached their final height (Table [1](#Tab1){ref-type="table"}, Fig. [3](#Fig3){ref-type="fig"}). The tandem CBM29-1-2-expressing plants continued to increase in height until the eleventh week, however, when they reached their final height, an average of 58 cm. There was, as a result, no significant difference between the heights of the tandem CBM29-1-2 lines at maturity and the heights of the single CBM29-2 lines, the pGreen vector control, and the wild-type control plants. There was no significant difference, at any time, between stem elongation of transgenic plants expressing CBM29-2 and the control plants. Table 1Plant height (cm) of transgenic lines CBM 29-1-2, CBM 29-2, empty pGreen7k control, and wild-type controlPlant lineWeeks after transplant3456789CBM29-1-29.5 ± 1.316.1 ± 2.227.0 ± 3.837.7 ± 5.543.1 ± 5.3^a^50.5 ± 5.4^a^56.6 + 6.7CBM29-29.3 ± 1.316.9 ± 1.927.5 ± 3.240.9 ± 5.050.7 ± 4.157.8 ± 4.163.8 + 4.7PGreen7k9.5 ± 1.617.3 ± 2.330.1 ± 3.844.6 ± 5.257.6 ± 7.163.1 ± 5.865.4 + 5.6WT Ctrl9.7 ± 1.317.1 ± 2.331.5 ± 3.750.6 ± 7.363.6 ± 7.168.4 ± 5.568.8 + 5.6The values are means and standard deviations for six transgenic lines (high expressers) and six control plants. Each line has three individual plants (three replicates)^a^Plant height significantly different from that of controlsFig. 3Reduced stem elongation in time, and delayed development of CBM 29-1-2 transgenic tobacco plants. The picture was taken at week eight

In addition to reduced stem elongation it was also observed that flower development was delayed in the tandem CBM29-1-2-expressing plants. We observed that at week eight, when most plants had already flowered (Fig. [3](#Fig3){ref-type="fig"}) and set fruit (data not shown), the tandem CBM29-1-2-expressing plants were just developing flower buds (Fig. [3](#Fig3){ref-type="fig"}). The flower buds eventually developed into normal flowers and also set fruits. Most plants, except the CBM29-1-2 plants, had also lost many leaves, because of faster ageing (Fig. [3](#Fig3){ref-type="fig"}).

There was no morphological or developmental change in the transgenic plants expressing the tandem CBM2[b]{.ul}-1-2 gene compared with the pGreen7k vector control. The average plant height of the tandem CBM2[b]{.ul}-1-2 series at maturity was 71 cm, which was comparable with the 75 cm average height for their pGreen7k vector control plants. We also did not observe a particular trend in plant development with regard to stem elongation, leaf abscission, or flower formation.

Cellular alterations are observed in transgenic plants {#Sec18}
------------------------------------------------------

The cellular basis for the CBM29-1-2 plant phenotypes was examined by histological examination of the transgenic tobacco stems. The examination revealed a prominent layer of collapsed cells in the cortex of the stems of the tandem CBM29-1-2-expressing plants (Figs. [4](#Fig4){ref-type="fig"}a, [5](#Fig5){ref-type="fig"}a). We also observed that this morphological alteration is consistently more severe in the high expressers than in the low expressers. This alteration was also observed in the high expressers of the single CBM29-2, although it was much less severe (Fig. [4](#Fig4){ref-type="fig"}c). For the CBM2[b]{.ul}-1-2 stems, irregularly shaped cells were observed in the cortex of the high expressers (Fig. [5](#Fig5){ref-type="fig"}c). The micrographs of both the empty vector control and untransformed wild-type control looked the same; hence the pGreen7k micrograph was taken to represent the controls (Fig. [4](#Fig4){ref-type="fig"}b). Altered cell enlargement across the tissues in the CBM29s-expressing stems was also observed. This was particularly true for the tandem CBM29-1-2-expressing plants (compare, for example, Figs. [5](#Fig5){ref-type="fig"}a and [5](#Fig5){ref-type="fig"}d with [5](#Fig5){ref-type="fig"}b/c and [5](#Fig5){ref-type="fig"}e/f, respectively). The altered cell size phenotype is widespread in the high and low CBM29-1-2-expressing plants. This is not observed, however, in the single CBM29-2-expressing stems, in which only the high expressers had noticeably larger cells in the epidermal, cortex, and xylem tissues than those of the controls. Similarly, there was an indication of larger xylem cells in the outermost layer of the CBM2[b]{.ul}-1-2 stems than in controls (compare Figs. [5](#Fig5){ref-type="fig"}e and [5](#Fig5){ref-type="fig"}f). There was, however, no clear indication of altered enlargement of the stem pith parenchyma cells of the transgenic plants. Fig. 4Cross sections of transgenic and control stems, showing collapsed cortical cells and enlarged cortical and xylem cells of the CBM29-1-2 stems. Sections of CBM29-1-2 (**a**), empty Pgreen7k control (**b**), CBM29-2 stem (**c**), and CBM2[b]{.ul}-1-2 (**d**) were stained with toluidine blue. *The boxed area* indicates tissues shown with higher magnification in Fig. [5](#Fig5){ref-type="fig"}. *ep* epidermis, *ct* cortex, *xy* xylem, *ph* pithFig. 5Magnification (10×) of cross sections of CBM29-1-2 stem (**a**, **d**), control stem (**b**, **e**), and CBM2[b]{.ul}-1-2 stem (**c**, **f**). Micrographs show collapsed cortical cells (**a**), enlarged cortical and xylem cells of the CBM29-1-2 stems (**a**, **d**), and irregularly shaped stem cortical cells of the CBM2[b]{.ul}-1-2 stems (**c**). *Asterisks* indicate irregular cortical cells in the CBM2[b]{.ul}-1-2 transformants; in the CBM29-1-2 transformants these cells are more apparent and are not highlighted. *ep* epidermis, *ct* cortex, *xy* xylem, *pf* phloem fibre

Cryo-scanning electron microscopy (cryo-SEM) of tobacco stems {#Sec19}
-------------------------------------------------------------

To establish that the transgenic stems indeed had larger cells than those of the controls we made cryo-SEM examinations of stem samples. Figure [6](#Fig6){ref-type="fig"}a shows the collapsed and enlarged cells of the cortex in the sections of transgenic line 5 of CBM29-1-2, as previously observed by light microscopic examination. The cortical cells of the control plant were smaller and the collapsed phenotype was not apparent (Fig. [6](#Fig6){ref-type="fig"}b). The micrographs also showed that xylem cells were indeed larger in the CBM29s-expressing stems than in the controls (compare transgenic line 5, Fig. [6](#Fig6){ref-type="fig"}c and the empty vector control, Fig. [6](#Fig6){ref-type="fig"}d). The micrographs also indicated that the cell walls of the xylem cells were thinner in the CBM29s-expressing stems (Fig. [6](#Fig6){ref-type="fig"}c) than in stems of controls (Fig. [6](#Fig6){ref-type="fig"}d). Similar micrographs were obtained for the CBM2[b]{.ul}-1-2 series, which confirmed that the radial surface area and cell wall diameter of their stem xylem cells were larger and thinner, respectively, than those of the controls (data not shown). These notable observations were later substantiated by quantification. Figure [7](#Fig7){ref-type="fig"}a shows that almost 50% and 40% of the stem cortical cells of the wild-type and pGreen7k control plants, respectively, were grouped in the small class (50--100 μm^2^), whereas fewer than 20% of the stem cortical cells of the CBM29s-expressing plants were grouped in the small class. An opposite trend was observed in the large class (150--200 μm^2^)---fewer than 20% of the cortical cells of the two control stems were grouped compared with more than 30 and 40% of the stems expressing the single CBM29-2 and the tandem CBM29-1-2, respectively. We thus infer that the cortical cells of the CBM29-2-expressing stems are larger than those of the control stems. Similar quantitative data were obtained from the xylem cells depicted in Fig. [7](#Fig7){ref-type="fig"}b, which shows that only the xylem cells of the CBM29-1-2-expressing stems are larger than those of the control stems. There was no difference between the size of the xylem cells of the single CBM29-2 stems and those of the controls. Similarly, we quantified the thickness of the cell walls of the xylem cells of the CBM29s-expressing stems and the pGreen7k control stems as presented in Fig. [7](#Fig7){ref-type="fig"}c. Approximately 45% of the cell walls of the xylem cells of the CBM29-1-2-expressing stem were grouped in the thin class (1.2--2 μm) whereas fewer than 10% of the stem xylem cell walls of the single CBM29-2, the pGreen7k control, and the wild-type control plants were grouped in this class. More than 60% of the xylem cell walls of the two control stems were grouped in the thick class (2.8--3.6 μm) whereas approximately 22 and 0% of the stem xylem cell walls of the single CBM29-2 and the tandem CBM29-1-2, respectively, were grouped in this class. We can also infer from this result that the thickness of the cell walls of the xylem cells of the CBM29-2-expressing stems (particularly of the tandem CBM29-1-2) are thinner than those of the pGreen7k and the wild-type control stems. Fig. 6Scanning electron micrographs of transgenic tobacco stems to show details of larger cells and thinner cell walls of the CBM 29-1-2 stems compared with the pGreen7k control. CBM29-1-2 (**a**) and (**c**), and empty pGreen7k control (**b**) and (**d**). **a** and **b** show the cortex tissue whereas **c** and **d** show the xylem tissue. *pf* phloem fibre, *xy* xylem, *ct* cortex. *Arrow heads* indicate collapsed layer of cortical cellsFig. 7Cell size distribution in the cortex (**a**), cell size distribution in the xylem (**b**), and cell wall thickness of xylem cells (**c**) in the stems of transgenic and the wild-type tobacco plants. *Insets* show how the surface area and wall thickness measurements were taken. Surface areas of 300 cells were measured, 100 cells per field of view. Cell wall diameters of 150 cells were measured, 50 cells per field of view. *Error bars* represent standard deviation. *Grey bars* represent wild-type plants. *Diagonal bars* represent empty pGreen7k transformants. *Open bars* represent single CBM29-2 transformants. *Horizontal brick bars* represent double CBM29-1-2 transformants

A similar trend was observed for the xylem cells of the CBM2[b]{.ul}-1-2 stems, which were larger than those of the pGreen7k control plants (data not shown). Similarly, the cell walls of the xylem cells of the CBM2[b]{.ul}-1-2-expressing stems were thinner than those of the pGreen7k control stems (data not shown).

Analysis of cellulose content {#Sec20}
-----------------------------

A colorimetric assay was performed on samples of crystalline cellulose obtained from four separate acid hydrolyses to determine the cellulose content in the stem cell walls of the CBM29s and CBM2[b]{.ul}-1-2 transformants and the control plants. There were no substantial differences between levels of cellulose in the stem cell walls of the transgenic tobacco lines expressing the single CBM29-2, the tandem CBM29-1-2, the tandem CBM2[b]{.ul}-1-2, the empty vector control, and the wild-type control plants (data not shown). Hence, it can be concluded that use of these CBMs for cell wall modification did not interfere with the extent of cellulose biosynthesis.

Discussion {#Sec21}
==========

It has been suggested that networks of plant cell wall polysaccharides can affect the properties of cellulose fibres. We hypothesized that expression of promiscuous CBMs in tobacco plants might lead to modification of these networks, although they might also affect plant development in more general terms. In this study, expression of two promiscuous *Piromyces* CBM29-containing proteins was targeted at tobacco cell walls to provide baseline information on the possibility of using CBMs for in-planta modification of the properties of cellulose fibre for industrial applications. In parallel, we also targeted the expression of the less promiscuous tandem CBM2[b]{.ul}-1-2 protein of the *C. fimi* xylanase 11A, with a view to comparing its effect with that of the more promiscuous CBM29-1-2.

Our results reveal that the tandem CBM29-1-2 modified the tobacco cell wall structure with consequent altered cellular and organ morphology. The tandem CBM29-1-2 modules had more effect than the single CBM29-2. Expression of the tandem CBM29-1-2 modules in the tobacco cell wall affected plant development, as reflected by reduced stem elongation rate, enlarged xylem, and collapsed cortical cells. The stem phenotype of the CBM29-1-2-expressing plants was more of delayed development of the whole plant rather than mere elongation defects of the stem. We suggest that the delayed development (prolonged juvenility) was as a result of reduced rate of anabolism in the tandem CBM29-1-2-expressing plant. It could be that structural remodelling of the cell wall has affected the normal developmental cues that signal the cells to synthesize new cell wall materials. It is conceivable that when the cell walls are held loosely continuously as a result of the continuous presence of CBM29-1-2, the rate of wall extension will outpace biosynthetic rate. Consequently, excessive thinning of the cell walls may occur (Kutschera [@CR20]), which may have led to the eventual collapse of, particularly, the primary walled cells (and not so much of the secondary-walled xylem cells). Thus, because of the extensive loosening of their cell walls and consequent altered expansion, the cortical cells may have yielded to tissue pressure within the stem. The altered cell enlargement, which led to the collapse of the cortical cells of the tandem CBM29-1-2-expressing stems, is proposed as the cellular basis for the reduced stem elongation. We have not noticed that the increased size of the xylem cells led to thicker stems. It is possible the gain in the size of the xylem cells is neutralized by the collapse of the cortical cells.

The explanation given above is based on the assumption that the CBMs do not bind to polymers until they have reached the wall. It should be noted, however, that by placing a signal peptide at the amino terminus of the CBMs we have targeted them through the secretory pathway, which includes the site of hemicellulose biosynthesis (the Golgi apparatus) (Denecke et al. [@CR11]; Vitale and Denecke [@CR42]). It is, therefore, possible the CBMs had already bound to hemicellulose before their deposition in the cell wall. As a result, the hemicellulose content, length, and/or branching pattern might have changed; this, in turn, could affect their interaction with cellulose microfibrils, leading to structural alteration of the cell wall.

The expression of the CBM2[b]{.ul}-1-2 modules in the tobacco cell wall altered the cellular morphology of the transgenic plants, as was apparent from the irregular shape of the cortical cells and altered cell enlargement of the xylem cells of the stems. The deformation of the cortical cells of the CBM2[b]{.ul}-1-2 expressing plants is, however, less pronounced than that of the cortical cells of the CBM29-1-2 transformants. The more obvious phenotypic changes in the CBM29-1-2-expressing plants is consistent with the result of the immunolabelling study with the proteins, which revealed that CBM29-1-2 binds to polysaccharides that are integral to both primary and secondary cell wall structure. CBM2[b]{.ul}-1-2, in contrast, binds only to xylan and non-crystalline cellulose. As xylan is mainly present in the secondary cell wall, it is not strange to see the effect of CBM2[b]{.ul}-1-2 most pronounced in the secondary walled xylem. The finding that CBM2[b]{.ul}-1-2 did not label the cortex (Fig. [2](#Fig2){ref-type="fig"}a) suggests that the deformation of the cortical cells is an indirect effect of CBM2[b]{.ul}-1-2. The cortical parenchyma has no secondary walls, suggesting that the walls are much weaker here; consequently, this tissue might collapse when challenged by excessive expansion of flanking tissues. The expression of the CBM2[b]{.ul}-1-2 only had effect on cellular morphology and not on plant morphology whereas the expression of the CBM29-1-2 in tobacco led to altered structural morphology and altered development of the transgenic plants. The reduced stem elongation phenotype of the CBM29-1-2 tobacco plants is, however, in contrast with the report by Safra-Dassa et al. ([@CR30]) of enhanced growth of transgenic potato plants expressing a bacterial CBM3. These contrasting results might be because of the different specificities of the CBMs, because we have used double CBMs in our investigation as opposed to the single CBM they used. That the experiments were performed on different plant species may also have contributed to the different observations.

There are reports attributing cell wall phenotypes in mutant or transgenic plants to abnormal wall assembly in general, or depletion of the cellulose content in particular (Szyjanowicz et al. [@CR34]; Taylor et al. [@CR36], [@CR35]; Tsabary et al. [@CR37]; Turner and Somerville [@CR38]). In all these instances the plants had deformed walls in vascular cells and reduced growth as a result of cellulose depletion. Our results reveal that wall deformation (cortical cells) can also occur without a marked reduction in cellulose content.

To summarise, the results of our investigation suggest that expression of the promiscuous tandem CBM29-1-2 can alter cell morphology to a larger extent than that of more specific CBM CBM2[b]{.ul}-1-2, although the actual effect is unpredictable. Use of CBMs for in-planta cell wall modification thus still needs further investigation.
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